Question 1

Does JPMorgan Chase own REGN stock?

Accepted Answer

Yes. As of its Q2 2026 13F, JPMorgan Chase holds 3,774,199 shares of REGN (Regeneron Pharmaceuticals), worth $2.4B.

Question 2

How many shares of REGN does JPMorgan Chase own?

Accepted Answer

As of its Q2 2026 13F, JPMorgan Chase holds 3,774,199 shares of REGN (Regeneron Pharmaceuticals).

Question 3

What is JPMorgan Chase's REGN position worth?

Accepted Answer

As of its Q2 2026 13F, JPMorgan Chase's REGN position is worth $2.4B.

Question 4

Is JPMorgan Chase buying or selling REGN?

Accepted Answer

In Q2 2026, JPMorgan Chase reduced its REGN position by 537,607 shares (-12.5%).

Question 5

When did JPMorgan Chase first buy REGN?

Accepted Answer

JPMorgan Chase already held REGN in its Q3 2024 13F, the earliest on record, and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	3.8M	-12.5%	$2.4B	0.1%	$622.81	0
2026-Q1	Increased	4.3M	+9.4%	$3.2B	0.2%	$770.59	42
2025-Q4	Decreased	3.9M	-3.3%	$3B	0.2%	$768.90	0
2025-Q3	Increased	4.1M	+3.4%	$2.3B	0.1%	$559.40	39
2025-Q2	Decreased	3.9M	-30.4%	$2.1B	0.1%	$521.53	0
2025-Q1	Decreased	5.7M	-19.9%	$3.6B	0.3%	$629.11	0
2024-Q4	Decreased	7.1M	-5.7%	$5B	0.4%	$705.67	0
2024-Q3	First report	7.5M	-	$7.9B	0.6%	$1,041.41	0